Peddock Capital Advisors, LLC Sarepta Therapeutics, Inc. Transaction History

Peddock Capital Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$72.25 - $168.95 $1,878 - $4,392	-26 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$125.56 - $178.74 $3,264 - $4,647	26 New	26 $4,000
Q1 2020 May 13, 2020	SELL	$82.38 - $131.64 $4,448 - $7,108	-54 Closed	0 $0
Q4 2019 Jan 24, 2020	BUY	$76.53 - $135.58 $4,132 - $7,321	54 New	54 $7,000
Q2 2019 Aug 06, 2019	SELL	$112.21 - $151.95 $6,059 - $8,205	-54 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$35.73 - $47.15 $1,929 - $2,546	54	54 $2,000

559

85.5M

3.67M

1.75M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.5B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Peddock Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Peddock Capital Advisors, LLC with notifications on news.